Clinical studies recruiting near Helsinki

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Helsinki University Hospital - Comprehensive Cancer Center ( · Pfizer · NCT05020236 Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
NA · Heart and Lung Center, University of Helsinki · University Hospital, Geneva · NCT06207383 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Docrates Syöpäsairaala · Pfizer · NCT07028853 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · New Children's Hospital · Princess Maxima Center for Pediatric Oncology · NCT05327894 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Helsinki University Hospital - Comprehensive Cancer Center ( · Merck Sharp & Dohme LLC · NCT06393374 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Helsinki University Comprehensive Cancer Center · Miltenyi Biomedicine GmbH · NCT04844866 A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · Site FI35801 · Astellas Pharma Global Development, Inc. · NCT05970172 Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
Phase 3 · Helsinki University Hospital · Uppsala University · NCT06488482 Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies
Phase 3 · helsingin yliopistollinen sairaala comprehensive cancer cent · Lakefront Biotherapeutics NV · NCT06652633 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Uusi Lastensairaala · PedAL BCU, LLC · NCT05183035 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Helsinki University Hospital · Amgen · NCT07037433 A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034 Prenatal Programming of Childhood Obesity and Cardio Metabolic Disorders
Phase N/A · Saila Koivusalo · Helsinki University Central Hospital · NCT05223530 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · HUS-Yhtymä, Helsingin yliopistollinen sairaala (HUS) - Uusi · Bayer · NCT07192952 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · New Children's Hospital · Eli Lilly and Company · NCT07222332 Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis
NA · Natural Resources Institute Finland · Natural Resources Institute Finland · NCT06390696 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Helsinki University Hospital - Comprehensive Cancer Center ( · Pfizer · NCT07144280 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0072 · Celgene · NCT05519085 A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated E
Phase N/A · Research Site · AstraZeneca · NCT05663515 A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours
Phase 1/Phase 2 · Helsinki university Hospital · Orion Corporation, Orion Pharma · NCT06725758 ReDirection / Self-Guided ICBT to Reduce the Risk of Child Sexual Abuse Material (CSAM) Use
NA · Protect Children NGO · The Royal Ottawa Mental Health Centre · NCT06778044 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Helsinki University Central Hospital, Meilahti hospital · Boehringer Ingelheim · NCT07220083 SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · Helsingin Yliopistollinen Keskussairaala · SAb Biotherapeutics, Inc. · NCT07187531 Post-Cholecystectomy Quality of Life
Phase N/A · Helsinki University Central Hospital · NCT03326154 A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Department otorhinolaryngology - Head and Neck Surgery, Hels · Eli Lilly and Company · NCT06338995 Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Phase 2 · Clinical Site · Intra-Cellular Therapies, Inc. · NCT06480383 KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC)
Phase 2 · HYKS Syöpätautien klinikka ( Site 0260) · Merck Sharp & Dohme LLC · NCT07252739 Emotional Bodymaps in Pediatric Pain Patients and Their Parents.
Phase N/A · New Childrens Hospital · Helsinki University Central Hospital · NCT05902234 Pan Tumor Rollover Study
Phase 2 · Local Institution · Bristol-Myers Squibb · NCT03899155 A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Helsinki university hospital · Pfizer · NCT06629779

Look up another city

Look up another condition